Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Meir Goldsmith

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|November 25, 2024
Lipid Nanoparticles With Fine-Tuned Composition Show Enhanced Colon Targeting as a Platform for mRNA TherapeuticsRiccardo Rampado, Gonna Somu Naidu, Olga Karpov, et al.
Immunology Letters|November 3, 2010
A ceramide analog inhibits cPLA(2) activity and consequent PGE(2) formation in LPS-stimulated macrophagesMeir Goldsmith, Ala Daka, Nadia F Lamour, et al.
Immunology Letters|February 3, 2009
Modulation of TNFalpha, IL-10 and IL-12p40 levels by a ceramide-1-phosphate analog, PCERA-1, in vivo and ex vivo in primary macrophagesDorit Avni, Meir Goldsmith, Orna Ernst, et al.
Advanced Materials (Deerfield Beach, Fla.)|January 19, 2022
Dual-Targeted Lipid Nanotherapeutic Boost for Chemo-Immunotherapy of CancerSeok-Beom Yong, Srinivas Ramishetti, Meir Goldsmith, et al.
Nanoscale|February 27, 2014
Tumor targeting profiling of hyaluronan-coated lipid based-nanoparticlesShoshy Mizrahy, Meir Goldsmith, Shani Leviatan-Ben-Arye, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|July 25, 2021
Therapeutic inhibitory RNA in head and neck cancer via functional targeted lipid nanoparticlesLiyona Kampel, Meir Goldsmith, Srinivas Ramishetti, et al.
Nanoscale|January 7, 2020
An ovarian spheroid based tumor model that represents vascularized tumors and enables the investigation of nanomedicine therapeuticsManu Smriti Singh, Meir Goldsmith, Kavita Thakur, et al.
ACS Nano|June 5, 2015
Systemic Gene Silencing in Primary T Lymphocytes Using Targeted Lipid NanoparticlesSrinivas Ramishetti, Ranit Kedmi, Meir Goldsmith, et al.
Cancer Letters|September 1, 2012
Hyaluronan grafted lipid-based nanoparticles as RNAi carriers for cancer cellsDalit Landesman-Milo, Meir Goldsmith, Shani Leviatan Ben-Arye, et al.
Immunology|September 17, 2008
A ceramide-1-phosphate analogue, PCERA-1, simultaneously suppresses tumour necrosis factor-alpha and induces interleukin-10 production in activated macrophagesMeir Goldsmith, Dorit Avni, Galit Levy-Rimler, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|November 25, 2024
Lipid Nanoparticles With Fine-Tuned Composition Show Enhanced Colon Targeting as a Platform for mRNA TherapeuticsRiccardo Rampado, Gonna Somu Naidu, Olga Karpov, et al.
Immunology Letters|November 3, 2010
A ceramide analog inhibits cPLA(2) activity and consequent PGE(2) formation in LPS-stimulated macrophagesMeir Goldsmith, Ala Daka, Nadia F Lamour, et al.
Immunology Letters|February 3, 2009
Modulation of TNFalpha, IL-10 and IL-12p40 levels by a ceramide-1-phosphate analog, PCERA-1, in vivo and ex vivo in primary macrophagesDorit Avni, Meir Goldsmith, Orna Ernst, et al.
Advanced Materials (Deerfield Beach, Fla.)|January 19, 2022
Dual-Targeted Lipid Nanotherapeutic Boost for Chemo-Immunotherapy of CancerSeok-Beom Yong, Srinivas Ramishetti, Meir Goldsmith, et al.
Nanoscale|February 27, 2014
Tumor targeting profiling of hyaluronan-coated lipid based-nanoparticlesShoshy Mizrahy, Meir Goldsmith, Shani Leviatan-Ben-Arye, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|July 25, 2021
Therapeutic inhibitory RNA in head and neck cancer via functional targeted lipid nanoparticlesLiyona Kampel, Meir Goldsmith, Srinivas Ramishetti, et al.
Nanoscale|January 7, 2020
An ovarian spheroid based tumor model that represents vascularized tumors and enables the investigation of nanomedicine therapeuticsManu Smriti Singh, Meir Goldsmith, Kavita Thakur, et al.
ACS Nano|June 5, 2015
Systemic Gene Silencing in Primary T Lymphocytes Using Targeted Lipid NanoparticlesSrinivas Ramishetti, Ranit Kedmi, Meir Goldsmith, et al.
Cancer Letters|September 1, 2012
Hyaluronan grafted lipid-based nanoparticles as RNAi carriers for cancer cellsDalit Landesman-Milo, Meir Goldsmith, Shani Leviatan Ben-Arye, et al.
Immunology|September 17, 2008
A ceramide-1-phosphate analogue, PCERA-1, simultaneously suppresses tumour necrosis factor-alpha and induces interleukin-10 production in activated macrophagesMeir Goldsmith, Dorit Avni, Galit Levy-Rimler, et al.
Pageof 4